About PPA   |   Sign In   |   Join Now
Substance Use Disorder: Identification and Referral Part I

A Special Certificate Program Delivered in Two Parts


The Substance Use Disorder Certificate Program is an innovative program designed to assist health care practitioners in identifying substance use issues, conducting an assessment, and making referrals.  The program is comprised of online home study modules and in-person live components. The online home study module and the one-day, live, in-person session total 17.00 credit hours of educational content. Participants will receive a Certificate of Achievement upon successful completion of the program.  Completion includes Part I and Part II as well as the post assessment:


  • Self-study activities (10.00 hours)
  • Live Interactive seminar (7 hours)
  • Post-seminar assessment

Part I is the prerequisite for Part II and must be completed prior to attending Part II.


Co-Developed with Duquesne University.  Duquesne is the recipient of a grant from AmeriSource Bergen Foundation.


Substance Use Disorder: Identification and Referral Part I






Click here for information on Part II

Following the online program, register for the live program - click here for more information!


UAN: 0159-0000-19-014-H01-P
Activity Type:
Contact Hours:
10.00 or (1.00 CEU)

Release Date: 7/01/2019

Expiration Date: 7/01/2022


Target Audience: 


Delivered in Nine Modules to complete at your own pace

1. Epidemiology of Substance Use Disorder

2. Disease Model of Addiction

3. Substances of Abuse

4. Signs and Symptoms of Substance Use Disorders

5. PDMP as a Tool

6. Screening Instruments and Assessments

7. Interventions

8. Motivational Interviewing

9. Warm Hand-Offs


Educational Objectives:


At the completion of this activity, the participant will be able to:

  1.  Differentiate observational studies from experimental studies
  2. Describe the biopsychosocial approach to health
  3. Explain the Adverse Childhood Experiences Study
  4. List risk and prognostic factors related to substance disorders
  5. Name factors that affect the distribution and metabolism of drugs of abuse
  6. Explain the steps of neurotransmission
  7. Describe the reward pathway of the brain and natural rewards
  8. Explain how neurotransmitters are altered by drugs of abuse
  9. Define addiction, tolerance, dependence, and withdrawal
  10. Explain the role of tolerance in drug overdoses
  11. Describe addiction as a disease model
  12. Describe the relationship between stigma and barriers to the assessment of Substance Use Disorders
  13. Explain the general characteristics of Substance Use Disorders
  14. Explain the symptoms of Substance Use Disorders
  15. Explain the indicators of drug seeking behavior
  16. Describe why Pennsylvania and other states have adopted the Prescription Drug Monitoring Program (PDMP)
  17. Identify the main purposes of the PDMP
  18. Discuss the legal requirements for pharmacists and prescribers in relationship to the PDMP
  19. Review how prescribers, dispensers and designated assistants use the PDMP
  20. Describe the Screening, Brief Intervention, and Referral to Treatment (SBIRT) approach
  21. Review the use of evidence-based screening tools for substance use disorders
  22. Determine which screening tool to use given a patient case and interpret screening results
  23. Discuss barriers and solutions to implementing screening for substance use disorders
  24. Explain the purpose of an intervention
  25. Identify the types of interventions
  26. Provide an overview of each type of intervention
  27. Determine the type of intervention that is most appropriate for a given situation
  28. Define a warm hand-off
  29. Identify the role of members of the healthcare team, including patient navigators and other stakeholders, in the warm hand-off
  30. Discuss the step-wise process in conducting a warm hand-off in a health-system setting
  31. Discuss the step-wise process in conducting a warm hand-off in a community/outpatient setting
  32. Identify resources for the assessment and treatment of substance use disorders that can be used in the development of a protocol
  33. Describe how motivational interviewing (MI) can be used to effectively promote behavior change
  34. Review MI techniques and skills to utilize in behavior change interventions
  35. Observe a brief intervention using motivational interviewing (MI) techniques to elicit change talk
  36. List the main classifications of drugs of abuse
  37. Give examples of drugs in each class
  38. Explain the schedule classification of drugs and give examples in each schedule
  39. Explain the mechanism of action of each class of drugs and how that is related to addiction
  40. List street names of the commonly abused drugs
  41. Explain the difference between opiates and opioids
  42. Explain in your own words how addiction is a disease 



Accreditation Statements


The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



Faculty Information



 Janet K. Astle, BS Pharm, EdD, Assistant Dean for Student Services

Duguesne University School of Pharmacy



Suzanne Higginbotham, B.S., Pharm.D., BCACP

Director of Center for Pharmacy Care, Residency Programs and Continuing

Pharmacy Education





Holly C. Lassila, DrPH, MSEd, RPh, LPC

Associate Professor Pharmacy Practice

Duquesne University School of Pharmacy



Jane E. Cavanaugh, Ph.D.

Associate Professor of Pharmacology

Duquesne University

Graduate School of Pharmaceutical Sciences School of Pharmacy


  Dr. Robert L. Maher Jr., BS, Pharm.D., BCGP



 Roshni S. Patel, PharmD, BCPS

Assistant Professor of Pharmacy Practice

Jefferson College of Pharmacy



 Vincent Giannetti, M.A., M.s., M.S.W., Ph.D


Duquesne University School of Pharmacy

Association Management Software Powered by YourMembership  ::  Legal